Search for: "Tom Lamb" Results 501 - 520 of 1,045
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jul 2012, 2:17 pm by Tom Lamb
Greater Risk For Uveitis, Scleritis, And Other Ocular Side Effects According To Two Recent Medical Journal Articles (Posted by Tom Lamb at DrugInjuryWatch.com) Fosamax, Boniva, and other osteoporosis medications in the bisphosphonates drug class have been linked to osteonecrosis of the jaw (ONJ) and atypical femur fractures, with both of these side effects getting considerable coverage in the popular press for some years now. [read post]
6 Jul 2012, 1:02 pm by Tom Lamb
New Medical Journal Article Provides More Information About Emerging Drug Safety Issue Involving Avandia / Actos Side Effect Affecting Sight And Vision (Posted by Tom Lamb at DrugInjuryWatch.com) According to a recent medical journal article, "Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes", published online in June 2012 by the Archives of Internal Medicine, the diabetes drugs Actos (pioglitazone) and… [read post]
3 Jul 2012, 7:36 am by Gary L. Francione
Sixth, I reiterate: the arguments for animal rights that I have developed over the past 30 years, which are very different from the positions developed by Peter Singer and Tom Regan, rest on logic and rationality. [read post]
28 Jun 2012, 2:45 pm by Tom Lamb
Medical Journal Article Reports Pradaxa-Induced Rectal Bleeding And Hemostatic Disorder In Two Elderly Patients (Posted by Tom Lamb at DrugInjuryWatch.com) On May 31, 2012 the Institute for Safe Medication Practices (ISMP) released its 2011 Annual Report Issue (PDF) which included new data for the second half of 2011 found in the FDA Adverse Event Reporting System (AERS), which consists of serious drug side effects information taken from FDA MedWatch reports. [read post]
28 Jun 2012, 2:45 pm by Tom Lamb
Medical Journal Article Reports Pradaxa-Induced Rectal Bleeding And Hemostatic Disorder In Two Elderly Patients (Posted by Tom Lamb at DrugInjuryWatch.com) On May 31, 2012 the Institute for Safe Medication Practices (ISMP) released its 2011 Annual Report Issue (PDF) which included new data for the second half of 2011 found in the FDA Adverse Event Reporting System (AERS), which consists of serious drug side effects information taken from FDA MedWatch reports. [read post]
28 Jun 2012, 2:45 pm by Tom Lamb
Medical Journal Article Reports Pradaxa-Induced Rectal Bleeding And Hemostatic Disorder In Two Elderly Patients (Posted by Tom Lamb at DrugInjuryWatch.com) On May 31, 2012 the Institute for Safe Medication Practices (ISMP) released its 2011 Annual Report Issue (PDF) which included new data for the second half of 2011 found in the FDA Adverse Event Reporting System (AERS), which consists of serious drug side effects information taken from FDA MedWatch reports. [read post]
22 Jun 2012, 2:30 pm by Tom Lamb
New 2012 Medical Journal Article By North Carolina Orthopedic Surgeon Presents Series Of Femoral Stress Fractures In Patients Using Fosamax Or Other Bisphosphonates (Posted by Tom Lamb at DrugInjuryWatch.com) William G. [read post]
12 Jun 2012, 2:39 pm by Tom Lamb
Other DRSP Birth Control Pills Which Are Implicated By This New Finding Include Beyaz, Safyral, Ocella, Gianvi, Zarah, Loryna, Syeda, And Vestura (Posted by Tom Lamb at DrugInjuryWatch.com) In the February 1, 2012 edition of Current Drug Safetythere is an article, "Irritable bowel syndrome and drospirenone-containing oral contraceptives; a comparative-safety study", which just came to our attention in June 2012. [read post]
5 Jun 2012, 2:35 pm by Tom Lamb
Pradaxa Adverse Reactions And Serious Bleeding Events More Common In Older Patients And Females, With Reduced Renal Function Also Being A Factor (Posted by Tom Lamb at DrugInjuryWatch.com) In April 2012 the manufacturer of Pradaxa (dabigatran), Boehringer Ingelheim, announced it is launching the GLORIA TM-AF Registry Program, which is designed to gather real-world data on patient demographics, disease characteristics, treatment decisions, and the safety and efficacy of Pradaxa as… [read post]
5 Jun 2012, 2:35 pm by Tom Lamb
Pradaxa Adverse Reactions And Serious Bleeding Events More Common In Older Patients And Females, With Reduced Renal Function Also Being A Factor (Posted by Tom Lamb at DrugInjuryWatch.com) In April 2012 the manufacturer of Pradaxa (dabigatran), Boehringer Ingelheim, announced it is launching the GLORIA TM-AF Registry Program, which is designed to gather real-world data on patient demographics, disease characteristics, treatment decisions, and the safety and efficacy of Pradaxa as… [read post]
30 May 2012, 1:37 pm by Tom Lamb
Researchers Find Increased Number Of Low-Energy Subtrochanteric Fractures For A Period Ten Years After Introduction Of Fosamax In That Country (Posted by Tom Lamb at DrugInjuryWatch.com) At the Orthopaedic Proceedings section of the Journal of Bone & Joint Surgery, British Volume, web site there is an item that presents some findings from a recent Australian study which supports the apparent link between Fosamax and atypical femur fractures. [read post]
30 May 2012, 1:37 pm by Tom Lamb
Researchers Find Increased Number Of Low-Energy Subtrochanteric Fractures For A Period Ten Years After Introduction Of Fosamax In That Country (Posted by Tom Lamb at DrugInjuryWatch.com) At the Orthopaedic Proceedings section of the Journal of Bone & Joint Surgery, British Volume, web site there is an item that presents some findings from a recent Australian study which supports the apparent link between Fosamax and atypical femur fractures. [read post]
27 May 2012, 8:23 am by Charon QC
” But however much we might admire judges like Tom Bingham, the rule of law must not mean rule by lawyers. [read post]
22 May 2012, 1:11 pm by Tom Lamb
Using These Bisphosphonates More Than Three (3) To Five (5) Years May Not Only Increase Side Effect Risk But There May Be No Benefit To Most Patients (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2012 there were medical journal articles in The New England Journal of Medicine (NEJM) and the Archives of Internal Medicine which, together, may cause millions of women to stop using the popular osteoporosis drugs Fosamax (or alendronate, its generic equivalent), Boniva,… [read post]
16 May 2012, 12:03 pm by Tom Lamb
Perhaps These Conflicting Findings As Regards Serious NuvaRing Side Effects (PE, DVT, Stroke) Will Prompt FDA To Convene An Advisory Committee Meeting To Consider Safety Of This Vaginal Ring (Posted by Tom Lamb at DrugInjuryWatch.com) Some conflicting and rather disturbing data about the safety of Merck's NuvaRing vaginal ring birth control method emerged in early May 2012 from two different medical studies. [read post]
11 May 2012, 7:18 am by Jennifer
Lincoln by Janis Cooke Newman Cleopatra by Stacy Schiff (Mugar DT 92.7 .S35 2010) Horror The Shining by Stephen King The Silence of the Lambs by Thomas Harris Watchers by Dean Koontz Mysteries Death and the Penguin by Andrey Kurkov Romances On the Island by Tracey Garvis Graves Science Fiction The God of Mars by Edgar Rice Burroughs Thrillers Agent 6 by Tom Rob Smith Children’s I am a Pole and So Can You by Stephen Colbert NONFICTION Biography Prague Winter by… [read post]
9 May 2012, 12:51 pm by Tom Lamb
825 Lawsuits Are Part Of New Jersey State Court Mass Tort Consolidation; Majority Of Other Cases Are Filed In "Second" Fosamax Federal Court MDL (Posted by Tom Lamb at DrugInjuryWatch.com) The following information about the number of Fosamax - femur fracture lawsuits that had been filed before January 2012 comes from pages 117-118 of the Merck & Co., Inc. [read post]
4 May 2012, 2:02 pm by Tom Lamb
A Drug Safety Controversy Continues: Whether It Is The Diabetes Drug Or The Diabetes Which Causes Pancreas Disease (Posted by Tom Lamb at DrugInjuryWatch.com) As regards the possible association between Victoza and pancreatitis as a side effect of this diabetes drug from Novo Nordisk, there have quite a few assorted developments during the period April 2011 to April 2012. [read post]
30 Apr 2012, 1:49 pm by Tom Lamb
While Mediations And Negotiations Continue, The First Scheduled YAZ / Yasmin Trials In Federal And State Courts Are Postponed Indefinitely (Posted by Tom Lamb at DrugInjuryWatch.com) In late April 2012 Bayer announced that it has settled lawsuits involving YAZ and Yasmin side effects related to blood clots, namely deep vein thrombosis (DVT) and pulmonary embolism (PE) cases. [read post]
24 Apr 2012, 1:04 pm by Tom Lamb
Recent Medical Article And Poster Presentation Both Point To A Trend Toward Increased Rate Or Risk Of Myocardial Infarction (MI) (Posted by Tom Lamb at DrugInjuryWatch.com)  A recent "position paper" by a group of experts from the European Society of Cardiology (ESC) Working Group on Thrombosis provides an update on the side effects associated with Pradaxa (dabigatran). [read post]